Designing clinical trials for a complex disease: pediatric obesity
Addressing the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed clinical trials.
In Association With ICON Biotech
Meet critical milestones
Oncology R&D: emerging therapies and new challenges
Overcoming the first hurdles: Navigating early phase challenges for biotechs
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
Cancer therapies for young adults: The need for tailored treatment and diversity
Diabesity: Overlapping pathophysiology informs multi-indication treatment
